Jan 23, 2025 · Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. Our fourth quarter results demonstrate tangible progress in improving our operations in response to the dynamic environment facing the industry.

Jan 24, 2024 · The increase in the quarter and year was driven by higher premium revenue in our Health Benefits segment and growth in pharmacy product revenue in CarelonRx. The benefit …

Jan 23, 2025 · Elevance Health supports health at every life stage, offering health plans and clinical, behavioral, pharmacy, and complex-care solutions that promote whole health.

Jan 23, 2025 · Elevance Health's adjusted operating expense ratio stood at 9.9% for the fourth quarter and 10.6% for the full year, an improvement of 170 basis points and 70 basis points, respectively,...

About Elevance Health Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives.

Jan 31, 2025 · Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per ...

Jan 23, 2025 · The average estimate of 17 analysts surveyed by Zacks Investment Research was for earnings of $3.80 per share. The health insurer posted revenue of $45.44 billion in the period. Its adjusted ...

Jan 24, 2025 · Elevance Health Inc (NYSE:ELV) reported fourth-quarter adjusted diluted earnings per share of $3.84, consistent with prior expectations. The company achieved strong member retention in its...

Jan 24, 2025 · At Elevance Health, our teams quickly mobilized to facilitate access to essential health resources and provide much-needed aid to the communities impacted by this devastating event.

Jan 24, 2025 · Good morning, and welcome to Elevance Health fourth-quarter 2024 earnings conference call. My name is Nathan Rich, Vice President of Investor Relations. With us this morning on the earnings call are Gail Boudreaux, President and CEO; Mark Kaye, CFO; Pete Haytaian, President of Carelon; Morgan Kendrick, President of our commercial health benefits business; and Felicia Norwood, President of our ...